Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > Hey terd(s) why do bash the reason your still on the planet?
View:
Post by Dude51 on Jul 06, 2020 8:45pm

Hey terd(s) why do bash the reason your still on the planet?

2020-06-09 06:11 PT - News Release

Mr. Robert Farrell reports

KALYTERA ANNOUNCES DATA FROM STUDY IN RATS DEMONSTRATING PROOF OF CONCEPT FOR R-107 IN COVID-19 ASSOCIATED PAH

Proof of concept data in PAH were strongly positive, with R-107 preserving vascular function and restoring normal pulmonary arterial blood pressure in rats. These data demonstrated a return of pulmonary arterial blood pressure to normal baseline within 20 minutes after dosing with R-107, with no adverse impact on heart rate or peripheral arterial blood pressure. This extraordinary improvement was sustained for the full period of four hours of observation after dosing. Treatment with R-107 was not associated with apparent side effects: R-107 did not lower peripheral arterial blood pressure and it had no effect on heart rate. Taken together, these data signify that R-107 selectively lowered PAH and did not compromise peripheral hemodynamics. These preclinical findings are significantly superior in both their potency and duration of activity compared to results of currently marketed agents evaluated in the same animal models of PAH.
Pulmonary Arterial Hypertension
Pulmonary arterial hypertension (PAH) is a severe, chronic syndrome affecting the small pulmonary arteries (blood vessels which carry blood from the heart to the lungs to pick up oxygen).
FYI Covid is not a fan of the lungs. Were still on the right road, flatening the terds that we run over on our way to BoomTown....GLTA
Comment by losingmyshirt on Jul 06, 2020 8:59pm
I thought Kaly was on the way to making use all filthy rich with GVHD ? but now all people post is about Kaly and Covid?  Next week we might hear that Kaly is involved in a major gold discovery or that they have found a flip flop belonging to Jesus.   Reposting shiny words from a press release that the company put out means absolutely nothing. R107, big deal...There are major labs all ...more  
Comment by MiSdyngNASTY on Jul 06, 2020 10:54pm
It's painful yet hilarious watching these guys go down with the ship. I would almost feel bad for them if they weren't so bloody irritating. It sucks that they are going to lose their life savings but will be a great learning experience for them.
Comment by scaley on Jul 07, 2020 12:54am
Remember penny, bad things happen to bad people. You must be stressed completely out. You are a bad person and I hope for nothing but bad things for you. Something terminal . Oh yeah, you are a really pathetic basher bud , seriously.  And very ignorant. The best part of you is still stuck to the pintos backseat 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities